Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Tangible Net Worth Ratio
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Tangible Net Worth Ratio of 84.3% as of September 2025. This metric is calculated by deducting intangible assets (CN¥169.44 Million) from net assets (CN¥1.08 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 688488 book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jiangsu Aidea Pharmaceutical Co Ltd Tangible Net Worth Ratio (2016–2024)
This chart shows how Jiangsu Aidea Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 84.3%, reflecting net assets of CN¥1.08 Billion with intangible assets of CN¥169.44 Million CNY. Also explore net asset momentum of Jiangsu Aidea Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Jiangsu Aidea Pharmaceutical Co Ltd worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.1% | CN¥1.07 Billion | CN¥180.41 Million | CN¥1.87 Billion | ▲ +1.2 pp |
| 2023 | 81.9% | CN¥1.13 Billion | CN¥203.72 Million | CN¥1.75 Billion | ▼ -3.0 pp |
| 2022 | 84.9% | CN¥1.20 Billion | CN¥181.07 Million | CN¥1.66 Billion | ▼ -2.5 pp |
| 2021 | 87.4% | CN¥1.31 Billion | CN¥165.14 Million | CN¥1.43 Billion | ▼ -1.9 pp |
| 2020 | 89.2% | CN¥1.36 Billion | CN¥146.21 Million | CN¥1.45 Billion | ▲ +12.6 pp |
| 2019 | 76.6% | CN¥556.24 Million | CN¥130.02 Million | CN¥780.98 Million | ▼ -3.4 pp |
| 2018 | 80.0% | CN¥522.71 Million | CN¥104.49 Million | CN¥708.95 Million | ▼ -4.7 pp |
| 2017 | 84.7% | CN¥514.09 Million | CN¥78.45 Million | CN¥659.24 Million | ▲ +9.7 pp |
| 2016 | 75.0% | CN¥300.40 Million | CN¥74.97 Million | CN¥443.55 Million | — |